5
Pharmaceutical preparations for the treatment of chronic diseases, namely, alpha-1 antitrypsin deficiency, moderate to severe persistent asthma, pulmonary arterial hypertension, respiratory syncytial virus, chronic, moderate to severe plaque psoriasis, hereditary tyrosinemia type 1, autoimmune disorders and primary immune deficiencies, growth hormone deficiency, Fabry disease, rheumatoid arthritis, psoriatic arthritis, hemophilia, Gaucher disease, blepharospasm, cervical dystonia, hyperhidrosis, strabimus, multiple sclerosis, hypomobility associated with advanced Parkinson's disease, MPS 1, severe combined immunodeficiency disease, chronic granulomatour disease, severe malignant osterpetrosis; pharmaceutical preparations for use as blood clotting agents used in the control of hemophilia
35
Retail pharmacy services specializing in the control of chronic diseases; retail pharmacy services specializing in the control of hemophilia
44
Nursing care specializing in the treatment, prevention and control of chronic diseases; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, namely, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen